Skip to main content
Log in

Role of debridement and interferon in the treatment of dendritic keratitis

  • Published:
Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie Aims and scope Submit manuscript

Summary

In a controlled clinical study, 42 patients with dendritic keratitis were treated either with thermocautery plus human leukocyte interferon (HLI) or with minimal wiping debridement plus HLI. The results show that the efficiency with which primary debridement was carried out, determined the success of further therapy using interferon. We conclude that interferon works basically as a prophylactic agent and needs the support of further antiviral measures to be effective against dendritic keratitis.

Zusammenfassung

42 Patienten mit Keratitis dendritica wurden in einer kontrollierten Studie entweder mit einer Kombination aus Thermokauterung plus Humanleukozyteninterferon (HLI) oder mit einer Kombination behandelt, bei der vor der HLI-Therapie nur eine weniger effektive Wischabrasio durchgeführt wurde. Die Ergebnisse zeigen, daß der Wirkungsgrad des Interferons unmittelbar von der Gründlichkeit der vorhergehenden Abrasio abhängt. Hieraus schließen wir, daß Interferon klinisch im wesentlichen als antivirales Prophylaktikum wirkt und daß es zusätzlicher antiviraler Maßnahmen bedarf, damit Interferon die Heilung einer Keratitis dendritica beschleunigt.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Reference

  1. Cantell, K., Hirvonen, S., Mogensen, K.E., Pyhälä, L.: Human leukocyte interferon production, purification, stability and animal experiments. In: Waymouth C. (ed.), Proceedings of a Tissue Culture Association Workshop, In Vitro, 35–38, monograph No 3, Rockville, Md (1974)

  2. Coster, D.J., Falcon, M.G., Cantell, K., Jones, B.R.: Clinical experiences of human leukocyte interferon in the management of herpetic keratitis. Trans. Ophthalmol. Soc. UK. 97, 327–329 (1977)

    Google Scholar 

  3. Coster, D.J., Jones, B.R., Falcon, M.G.: Role of debridement in the treatment of herpetic keratitis. Trans. Ophthalmol. Soc. UK 97, 314–317 (1977)

    Google Scholar 

  4. Jones, B.R., Coster, D.J., Falcon, M.G., Cantell, K.: Topical therapy of ulcerative herpetic keratitis with human interferon. Lancet, II, 128 (1976)

    Google Scholar 

  5. Sundmacher, R., Neumann-Haefelin, D., Cantell, K.: Successful treatment of dendritic keratitis with human leukocyte interferon. A controlled clinical study. Albrecht v. Graefes Arch. klin. exp. Ophthal. 201, 39–45 (1976)

    Google Scholar 

  6. Sundmacher, R., Neumann-Haefelin, D., Manthey, K.F., Müller, O.: Interferon in treatment of dendritic keratitis in humans. A preliminary report. J. Infect. Dis. 133, Suppl., A160–164 (1976)

    Google Scholar 

  7. Wellings, P.C., Awdry, P.N., Bors, F.H., Jones, B.R., Brown, D.C., Kaufman, H.E.: Clinical evaluation of trifluorothymidine in the treatment of herpes simplex corneal ulcers. Am. J. Ophthalmol. 73, 932–942 (1972)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This investigation was supported by the Deutsche Forschungsgemeinschaft

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sundmacher, R., Cantell, K., Haug, P. et al. Role of debridement and interferon in the treatment of dendritic keratitis. Albrecht von Graefes Arch. Klin. Ophthalmol. 207, 77–82 (1978). https://doi.org/10.1007/BF00414304

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00414304

Keywords

Navigation